Send feedback

IFT172 p.Val33Ala

c.98T>C · rs200884031 · VCV719920

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 4 submitters
AlphaMissense
likely pathogenic
0.5898 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0165%, mid)
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
2
short-rib thoracic dysplasia 10 with or without polydactyly

Computational evidence

Protein change
AlphaMissense0.5898likely pathogenic
REVEL0.493indeterminate
SaProtLLR -8.48tolerated
⇒ AlphaMissense calls this damaging; SaProt does not; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 11GERP 2.5, phastCons 1
Regional constrainto/e 0.93unconstrained · MANE · 32 kb · p 0.013 · regional, not allelic
Overall
CADD25.8PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0165% Middle Eastern · 1/6,076 alleles
Filtering AF 0.00226% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00135%
Overall 0.00892% 144/1,614,024 alleles · ultra-rare exomes 122/1,461,812 · genomes 22/152,212 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.334% 299
Remaining individualsnot grpmax-eligible 0.0288% 3,472
Middle Easterngrpmax 0.0165% 6,076
Admixed American 0.00667% 15,001
European (non-Finnish) 0.00178% 56,191
African / African-American 0.00133% 74,910

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
IFT172
Protein
p.Val33Ala
Coding
c.98T>C
MANE Select
NM_015662
dbSNP
rs200884031
Type
single nucleotide variant
Location
chr2:27485445 (GRCh38)
Gene constraint
LOEUF 0.745 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 83.98 · 1 PDB
Full IFT172 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ift172-p-val33ala (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown